Introduction
Complementary characterisation techniques are often required in the study of biomolecular interactions and on the validation of biomolecular detection. Different electrochemical techniques can be used for fast, miniaturised biosensing systems, with each technique providing different information, which can then be correlated to a certain concentration of analyte. Often more than one technique is used to validate the biosensor or provide complementary information on the biological recognition system (e.g. kinetics and concentration). A few reports have integrated different techniques on the same measurement system in order to look at different properties of an interaction or validate the detection of an analyte [1, 2] . Such integrated systems open the doors towards generic biosensors that can be used for a range of applications, where the user selects which techniques to use according to the properties of the biomolecule to be measured or the information required.
We here describe the combination of several electrochemical (open circuit potential, electrochemical impedance spectroscopy, differential pulse voltammetry) and nanoplasmonic (localized surface plasmon resonance) techniques on a linear array of electrodes in a flow cell. These have been applied for the detection of protein phosphorylation driven by kinases.
Abnormal phosphorylation of proteins, interceded by kinases, is an important cellular regulation in several aspects of neoplasia [3] . Furthermore, there are over 400 diseases now linked either directly or indirectly to the activity of protein kinases [4] [5] [6] [7] . This makes protein kinases an abundant source of potential drug targets to intervene in several diseases.
However, the current kinase inhibitor drug market is very premature with less than 30 protein kinase inhibitors approved by the United States Food and Drug Administration until 2014 [8] . This is primarily due to the time consuming, cost inefficient and laborious detection techniques, like mass spectroscopy and western blot, used in pharmaceutics to understand the kinase activity. In addition, some of these assays require the usage of toxic chemical reagents, such as radioactive tags/label, and are unsuitable for high-throughput applications [9] . The need to develop high-throughput biosensors that are capable of screening large libraries of kinase inhibitors is therefore very high. In this work, we present a novel 3-step assay that enables parallel detection of protein phosphorylation by multiple electrochemical and nanoplasmonic techniques. In the first step, phosphorylation of myelin basic protein by PKC-α kinase is achieved by using 5'-[γ-thio] triphosphate (ATP-S) as a source of phosphate in the presence and absence of known inhibitor PKC-α, GF 109203X. The phosphorylation process is monitored in real time using an in-house built open circuit potential (OCP) measurement system. In the second step, gold nanoparticles are added to the reaction, which attach spontaneously to the thio-phosphoryl groups. This facilitates detection of phosphorylated proteins using a localized surface plasmon resonance technique as reported in our previous work [2, 10] . Finally, in the last step thiolated ferrocene (Fc) is added to the system, which is grafted onto the gold nanoparticles allowing detection of phosphorylation using differential pulse voltammetry (DPV) and electrochemical impedance spectroscopy (EIS). 
Experimental

Reagents
All chemicals were of analytical grade and were used as received, unless otherwise specified. 
Protein phosphorylation assay
The biosensor principle is described in Figure 1 . A mixed self-assembled monolayer (SAM) made of 1 mM MUA and MCH in a ratio of 1:9 MUA:MCH was immobilized overnight onto gold electrodes. In order to cover possible pinholes on the gold surface and to reduce nonspecific binding, a 1 h backfilling step was performed with 1 mM MCH. All further modification steps were carried out under a flow rate of 100 µl/min using a peristaltic pump 
Electrochemical measurements
A CompactStat potentiostat (Ivium Technologies, The Netherlands) was used to perform impedance measurements and DPV in a three-electrode cell with an Ag/AgCl reference electrode (BASi, USA) and a platinum wire counter electrode (ALS, Japan). A linear array of 4 gold electrodes with 2 mm diameter was prepared in-house by thermal evaporation (BOC Edwards, USA) of 20 nm Cr and 100 nm Au on glass slides. The electrode array was sonicated for 3 min in acetone followed by rinsing with ethanol and then ultrapure water.
Impedance measurements were recorded in the above mentioned reaction buffer, scanning the frequency between 100 KHz and 0.1 Hz applying a 10 mV a.c. voltage superimposed to the OCP. Since an ideal impedimetric sensor will measure the response at a single frequency rather than for a wide spectrum, localized values of resistance (Rl) and capacitance (Cl) were used for comparing the EIS signals. Rl and Cl were measured at the frequency that minimizes the imaginary response of the complex capacitance (defined as 1/jωZ) -in our system this was observed to be at 1 Hz throughout the different steps. Moreover, recording an EIS signal for a single frequency allowed to shorten the time of the measurement from ~3.5 min (sweeping the whole frequency range) to ~20 s. DPV was performed to monitor the Fc peak scanning the potentials vs Ag/AgCl and each measurement could be performed in ~10 s. All the measurements were carried out at least in triplicates.
Open Circuit Potential
The open circuit potential was measured in real time using a complete monolithic FET-input ultra low input bias current instrumentation amplifier INA116 (Texas Instruments, USA)
[11]. Difet® inputs, a very low input bias current of 3 fA at 25°C, with special guarding techniques were used to achieve the very low input bias current performance and provide an 
Localized surface plasmon resonance measurements
Once the electrochemical recordings were terminated, LSPR was measured using an in-house built system with discrete components, all bought from Ocean Optics (USA). The system had 3 parts: reflection probe (R400-7-UV-VIS) with both detector and light source, connected to a Tungsten Halogen source (LS-1-LL) and a spectroscope (USB4000-UV-VIS-ES). The data was obtained through absorption mode on a cross platform spectroscopy operation software (SPECTRASUITE) provided by Ocean Optics; each measurement lasted only a few seconds.
Results and Discussion
Prior to monitor thio-phosphorylation, the coverage of pinholes on the electrode surface by MCH backfilling was confirmed by means of EIS measurements: a decrease in capacitance signal of 11.3 ± 0.6% was observed, indicating the effectiveness of the backfilling process.
OCP was monitored in real time upon thio-phosphorylation of MBP immobilised onto the gold electrodes in a flow cell (Fig. 2A) . OCP showed a change of -30 mV upon protein thio- The final and perhaps most powerful tool to crosscheck the thio-phosphorylation event was
achieved by performing DPV measurements on the same platform (Fig. 2C) , which clearly showed the Fc peaks. An Fc peak of 1.31 ± 0.26 µA height (using baseline subtraction) was detected at 0.59 V, while no peak was observed for the controls.
Conclusions
This study describes a new multimodal biosensor approach, demonstrating the potential in combining multiple sensing techniques on a single platform to achieve high levels of accuracy and reliability in the measurements.
This multimodal biosensor was successfully applied using a small array of electrodes in a flow cell for detecting phosphorylation of proteins. We tested phosphorylation of MBP by PKC-alpha in the presence of a known inhibitor, however this approach can be used to assay activity of any kinase-protein pair in the presence of known/unknown inhibitors. This opens opportunities to develop an integrated device with multiple sensing technologies, as demonstrated, for pharmaceutical industries and academia to discover drugs. Moreover, it also exploits simple and cost-effective consumables to build a biosensor system for screening inhibitors of kinase.
Our multimodal approach can easily be translated to a range of other biosensing applications, such as biomedical and environmental, where different electrochemical techniques can be used to perform on-chip validation of true positives. The engineering of the biorecognition elements/reagents can allow the use of nanoparticles, redox molecules or other types of signal probes for signal validation and amplification.
